Market Insights
Articles
Latest
View All-
Running shoes propel On Holding to fast gains
While sportswear giants Nike (NYSE: NKE) and Adidas (CBOE: ADS) have struggled in recent years, On Holding (NYSE: ONON) is all the rage. Its stock has climbed 25% over the past five years, compared to drops of 71% for Nike and 41% for Adidas. Of course On’s increase pales in comparison to the S&P 500’s […]
-
Defense contractor L3Harris thrives amid global tension
Defense spending has surged around the world this year, thanks to spreading conflict such as the Mideast wars. But that dynamic hasn’t created outsized gains for defense stocks. The S&P Aerospace & Defense stock Index has climbed 9.3% year to date, trailing the S&P 500 index at 11%. L3Harris Technologies (NYSE: LHX) has particularly suffered, […]
-
Academy Sports & Outdoors ramps up online sales
Consumers are spending more of their leisure time and money pursuing interests such as playing tennis, going camping or staying more active as they focus on their health.. Fitness and sports enthusiasts have ramped up purchases of equipment and apparel, benefitting retailer Academy Sports & Outdoors (NASDAQ: ASO) whose sales have jumped by nearly 7% […]
-
Garmin’s navigation devices attract wearables, outdoor enthusiasts
Fitness and outdoor enthusiasts are devoted to the wearables and navigation products that Garmin (NYSE: GRMN) manufactures, resulting in revenue growing by double digits. While some consumers just want to count how many steps they have taken during the day, other shoppers are outdoor or nature lovers who add electronic devices to their excursions either […]
-
Will sweet and salty do the trick for Hershey?
Hershey (NYSE: HSY), the 132-year-old chocolate icon, isn’t just making tasty treats. It’s also producing sweet financial performance, as it raises its own prices and enjoys falling cocoa prices. The company’s revenue rose 6.6% in the second quarter from a year earlier – 3.6% on an organic basis, which excludes currency fluctuation and mergers. Its […]
-
Thermo Fisher Scientific’s deals fuel growth
Thermo Fisher Scientific (NYSE: TMO) works with biopharmaceutical companies to help them advance their clinical trials, design better testing, create breakthroughs and bring their drugs to the market. The scientific instruments company reported revenue during the second quarter increased by 10% to $11.99 billion while generating a profit of $1.74 billion, compared with $1.62 billion […]
